12-131941464-C-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_025215.6(PUS1):c.717C>A(p.Tyr239Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_025215.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PUS1 | NM_025215.6 | c.717C>A | p.Tyr239Ter | stop_gained | 5/6 | ENST00000376649.8 | NP_079491.2 | |
PUS1 | NM_001002019.3 | c.633C>A | p.Tyr211Ter | stop_gained | 5/6 | NP_001002019.1 | ||
PUS1 | NM_001002020.3 | c.633C>A | p.Tyr211Ter | stop_gained | 5/6 | NP_001002020.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PUS1 | ENST00000376649.8 | c.717C>A | p.Tyr239Ter | stop_gained | 5/6 | 1 | NM_025215.6 | ENSP00000365837 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152236Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74372
ClinVar
Submissions by phenotype
Myopathy, lactic acidosis, and sideroblastic anemia 1 Pathogenic:2
Likely pathogenic, criteria provided, single submitter | clinical testing | Knight Diagnostic Laboratories, Oregon Health and Sciences University | Sep 26, 2015 | The c.633C>A (p.Tyr211ter) novel nonsense variant in the PUS1 gene is predicted to cause a premature protein truncation that lacks 188 amino acids (NP_001002020) in the C-terminal region of the protein. The C-terminal portion, which is predicted to be deleted as a result of this variant, comprises three helices that are necessary to maintain structural integrity and stability (Czudnochowski N et al., 2013). Indeed, a mutant form of hPus1 that lacks the important three helical domains in the C-terminal end was unable to solubilize (Czudnochowski N et al., 2013). Furthermore, Fernandez-Vizarra E et al. (2007) reported that two brothers who were affected with MLASA carried a homozygous variant (p.Glu192ter) that was also predicted to ablate the three C-terminal helices of the protein. This locus is conserved across species. The frequency of this variant is either absent or very low in the population databases (1000 Genome, Exome Sequencing Project and ExAC) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 15, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at